Comparing BM and peripheral blood cells (PBCs) between AML patients and healthy donors (HDs), Fiedler and colleagues discovered that TIGIT was specifically expressed on CD56dimCD16+ NK cells from AML [131]. This evidence concerns the gene TIGIT and acute myeloid leukemia.